PHIO logo

Phio Pharmaceuticals (PHIO) Net Income

Annual Net Income

-$10.83 M
+$654.00 K+5.70%

December 1, 2023


Summary


Performance

PHIO Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPHIOprofitabilitymetrics:

Quarterly Net Income

-$1.52 M
+$322.00 K+17.44%

September 1, 2024


Summary


Performance

PHIO Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPHIOprofitabilitymetrics:

TTM Net Income

-$7.42 M
+$1.26 M+14.48%

September 1, 2024


Summary


Performance

PHIO TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPHIOprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

PHIO Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.7%+45.2%+36.4%
3 y3 years-23.1%+45.2%+36.4%
5 y5 years-47.1%+45.2%+36.4%

PHIO Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+18.5%at high+57.7%at high+44.2%
5 y5-year-23.1%+18.5%at high+59.3%at high+44.2%
alltimeall time-47.1%+48.3%-2.1%+89.4%-93.2%+70.7%

Phio Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.52 M(-17.4%)
-$7.42 M(-14.5%)
Jun 2024
-
-$1.85 M(-14.3%)
-$8.68 M(-7.5%)
Mar 2024
-
-$2.15 M(+13.7%)
-$9.38 M(-13.4%)
Dec 2023
-$10.83 M(-5.7%)
-$1.90 M(-31.8%)
-$10.83 M(-7.2%)
Sep 2023
-
-$2.78 M(+9.1%)
-$11.66 M(-6.4%)
Jun 2023
-
-$2.55 M(-29.2%)
-$12.46 M(+0.1%)
Mar 2023
-
-$3.60 M(+31.9%)
-$12.44 M(+8.4%)
Dec 2022
-$11.48 M(-13.6%)
-$2.73 M(-23.6%)
-$11.48 M(-5.9%)
Sep 2022
-
-$3.58 M(+41.3%)
-$12.20 M(-1.3%)
Jun 2022
-
-$2.53 M(-4.2%)
-$12.37 M(-1.2%)
Mar 2022
-
-$2.64 M(-23.4%)
-$12.52 M(-5.8%)
Dec 2021
-$13.29 M(+51.1%)
-$3.45 M(-7.8%)
-$13.29 M(+8.0%)
Sep 2021
-
-$3.74 M(+39.3%)
-$12.30 M(+13.2%)
Jun 2021
-
-$2.69 M(-21.1%)
-$10.87 M(+10.3%)
Mar 2021
-
-$3.41 M(+38.4%)
-$9.85 M(+12.0%)
Dec 2020
-$8.79 M(-1.3%)
-$2.46 M(+6.6%)
-$8.79 M(-2.2%)
Sep 2020
-
-$2.31 M(+38.1%)
-$8.99 M(+2.4%)
Jun 2020
-
-$1.67 M(-28.9%)
-$8.78 M(-4.0%)
Mar 2020
-
-$2.35 M(-11.6%)
-$9.14 M(+2.6%)
Dec 2019
-$8.91 M(+21.0%)
-$2.66 M(+27.0%)
-$8.91 M(+11.7%)
Sep 2019
-
-$2.09 M(+2.9%)
-$7.97 M(+8.2%)
Jun 2019
-
-$2.04 M(-4.0%)
-$7.37 M(+1.9%)
Mar 2019
-
-$2.12 M(+22.7%)
-$7.24 M(-1.6%)
Dec 2018
-$7.36 M(-40.9%)
-$1.73 M(+15.7%)
-$7.36 M(-3.6%)
Sep 2018
-
-$1.49 M(-21.5%)
-$7.63 M(-11.4%)
Jun 2018
-
-$1.90 M(-15.1%)
-$8.62 M(-6.6%)
Mar 2018
-
-$2.24 M(+11.8%)
-$9.23 M(-25.9%)
DateAnnualQuarterlyTTM
Dec 2017
-$12.45 M(+38.4%)
-$2.00 M(-19.1%)
-$12.45 M(-2.6%)
Sep 2017
-
-$2.48 M(-1.5%)
-$12.79 M(+2.1%)
Jun 2017
-
-$2.51 M(-54.0%)
-$12.53 M(+2.5%)
Mar 2017
-
-$5.46 M(+133.4%)
-$12.22 M(+35.9%)
Dec 2016
-$8.99 M(-12.0%)
-$2.34 M(+5.7%)
-$8.99 M(-3.0%)
Sep 2016
-
-$2.21 M(0.0%)
-$9.27 M(-3.0%)
Jun 2016
-
-$2.21 M(-0.9%)
-$9.55 M(+0.5%)
Mar 2016
-
-$2.23 M(-14.7%)
-$9.51 M(-7.0%)
Dec 2015
-$10.22 M(+16.2%)
-$2.62 M(+4.8%)
-$10.22 M(+3.1%)
Sep 2015
-
-$2.50 M(+15.2%)
-$9.91 M(+3.0%)
Jun 2015
-
-$2.17 M(-26.5%)
-$9.62 M(+1.7%)
Mar 2015
-
-$2.94 M(+27.8%)
-$9.46 M(+7.5%)
Dec 2014
-$8.80 M(-57.9%)
-$2.30 M(+4.4%)
-$8.80 M(-2.3%)
Sep 2014
-
-$2.21 M(+10.0%)
-$9.00 M(+1.7%)
Jun 2014
-
-$2.01 M(-12.2%)
-$8.86 M(+0.5%)
Mar 2014
-
-$2.28 M(-8.9%)
-$8.81 M(-57.9%)
Dec 2013
-$20.93 M(+62.5%)
-$2.51 M(+21.8%)
-$20.93 M(+4.0%)
Sep 2013
-
-$2.06 M(+5.0%)
-$20.13 M(+2.1%)
Jun 2013
-
-$1.96 M(-86.4%)
-$19.71 M(-22.2%)
Mar 2013
-
-$14.40 M(+740.9%)
-$25.35 M(+96.8%)
Dec 2012
-$12.88 M(+26.0%)
-$1.71 M(+4.1%)
-$12.88 M(-5.4%)
Sep 2012
-
-$1.64 M(-78.4%)
-$13.62 M(-2.8%)
Jun 2012
-
-$7.60 M(+294.5%)
-$14.02 M(+68.8%)
Mar 2012
-
-$1.93 M(-21.5%)
-$8.30 M(-18.7%)
Dec 2011
-$10.22 M
-$2.45 M(+20.1%)
-$10.22 M(+31.6%)
Sep 2011
-
-$2.04 M(+8.6%)
-$7.77 M(+35.7%)
Jun 2011
-
-$1.88 M(-51.0%)
-$5.72 M(+49.0%)
Mar 2011
-
-$3.84 M
-$3.84 M

FAQ

  • What is Phio Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Phio Pharmaceuticals?
  • What is Phio Pharmaceuticals annual net income year-on-year change?
  • What is Phio Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Phio Pharmaceuticals?
  • What is Phio Pharmaceuticals quarterly net income year-on-year change?
  • What is Phio Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Phio Pharmaceuticals?
  • What is Phio Pharmaceuticals TTM net income year-on-year change?

What is Phio Pharmaceuticals annual net profit?

The current annual net income of PHIO is -$10.83 M

What is the all time high annual net income for Phio Pharmaceuticals?

Phio Pharmaceuticals all-time high annual net profit is -$7.36 M

What is Phio Pharmaceuticals annual net income year-on-year change?

Over the past year, PHIO annual net profit has changed by +$654.00 K (+5.70%)

What is Phio Pharmaceuticals quarterly net profit?

The current quarterly net income of PHIO is -$1.52 M

What is the all time high quarterly net income for Phio Pharmaceuticals?

Phio Pharmaceuticals all-time high quarterly net profit is -$1.49 M

What is Phio Pharmaceuticals quarterly net income year-on-year change?

Over the past year, PHIO quarterly net profit has changed by +$1.26 M (+45.18%)

What is Phio Pharmaceuticals TTM net profit?

The current TTM net income of PHIO is -$7.42 M

What is the all time high TTM net income for Phio Pharmaceuticals?

Phio Pharmaceuticals all-time high TTM net profit is -$3.84 M

What is Phio Pharmaceuticals TTM net income year-on-year change?

Over the past year, PHIO TTM net profit has changed by +$4.24 M (+36.38%)